BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2501 – 2510 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Personalizing pancreatic cancer medicine: what are the challenges?
(
- Contribution to journal › Scientific review
-
Mark
The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
(
- Contribution to journal › Article
-
Mark
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
(
- Contribution to journal › Article
-
Mark
New Insights into the Carrier-Mediated Transport of Estrone-3-sulfate in the Caco-2 Cell Model
(
- Contribution to journal › Article
-
Mark
Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
(
- Contribution to journal › Article
-
Mark
Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
(
- Contribution to journal › Article
-
Mark
Physical activity during and after adjuvant chemotherapy in patients with breast cancer.
(
- Contribution to journal › Article
-
Mark
Pituitary disease mortality: is it fiction?
(
- Contribution to journal › Article
-
Mark
Effects of TGF-β signaling in Clear Cell Renal Cell Carcinoma cells.
(
- Contribution to journal › Article